Human Genome Epidemiology Literature Finder
|
Records 1 - 5 (of 5 Records) |
| Query Trace: Breast Neoplasms and TRPC6[original query] |
|---|
Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial.
Pharmacogenetics and genomics 2017 Jul . Serie Daniel J, Crook Julia E, Necela Brian M, Dockter Travis J, Wang Xue, Asmann Yan W, Fairweather DeLisa, Bruno Katelyn A, Colon-Otero Gerardo, Perez Edith A, Thompson E Aubrey, Norton Nadi |
| Association of Genetic Variants at TRPC6 With Chemotherapy-Related Heart Failure. Frontiers in cardiovascular medicine 2020 9 7 142. Norton Nadine, Crook Julia E, Wang Liwei, Olson Janet E, Kachergus Jennifer M, Serie Daniel J, Necela Brian M, Borgman Paul G, Advani Pooja P, Ray Jordan C, Landolfo Carolyn, Di Florio Damian N, Hill Anneliese R, Bruno Katelyn A, Fairweather DeLi |
| TRPC6 N338S is a gain-of-function mutant identified in patient with doxorubicin-induced cardiotoxicity. Biochimica et biophysica acta. Molecular basis of disease 2022 7 1868 (11): 166505. Lu Tong, Sun Xiaojing, Necela Brian M, Lee Hon-Chi, Norton Nadi |
| Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial. Frontiers in oncology 2023 6 13 1139347. Pooja P Advani, Kathryn J Ruddy, Joerg Herrmann, Jordan C Ray, Emily C Craver, Greg Yothers, Reena S Cecchini, Corey Lipchik, Huichen Feng, Priya Rastogi, Eleftherios P Mamounas, Sandra M Swain, Charles E Geyer, Norman Wolmark, Soonmyung Paik, Katherine L Pogue-Geile, Gerardo Colon-Otero, Edith A Perez, Nadine Nort |
| HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment. Cancers 2023 2 15 (3): . Novillo Apolonia, Gaibar María, Romero-Lorca Alicia, Malón Diego, Antón Beatriz, Moreno Amalia, Fernández-Santander A |
- Page last reviewed:Feb 1, 2024
- Content source: